APP C-terminal fragment levels and APP and tau hyperphosphorylation were decreased with 100 mg/kg berberine, administered by oral gavage for 4 months, via the Akt/glycogen synthase kinase 3 (GSK-3) pathway in rats with AD (Durairajan et al., 2012). The gene discussed is APP; the disease is Alzheimer disease.